$FLR
FLUOR CORP
CIK:0001124198|SEC Filings
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Income Statement [Abstract] | ||||||
| Revenue | $ 4,329 | $ 3,978 | $ 7,991 | $ 7,959 | ||
| Cost of revenue | (4,150) | (3,922) | (7,798) | (7,762) | ||
| Gross profit | 179 | 56 | 193 | 197 | ||
| G&A | (41) | (52) | (103) | (88) | ||
| Gain on sale of CFHI | 0 | 0 | 124 | 0 | ||
| Foreign currency gain (loss) | (3) | (30) | 12 | (44) | ||
| Operating profit (loss) | 135 | (26) | 226 | 65 | ||
| Interest expense | (11) | (9) | (21) | (21) | ||
| Interest income | 32 | 26 | 57 | 55 | ||
| Earnings (loss) before taxes | 156 | (9) | 262 | 99 | ||
| Income tax expense | [1] | (25) | (765) | (17) | (712) | |
| Net earnings (loss) before equity method earnings | 131 | (774) | 245 | (613) | ||
| Equity method earnings (loss) | (8) | 3,212 | 44 | 2,819 | ||
| Net earnings | 123 | 2,438 | 289 | 2,206 | ||
| Less: Net earnings (loss) attributable to NCI | 9 | (22) | 15 | (13) | ||
| Net earnings attributable to Fluor | $ 114 | $ 2,460 | $ 274 | $ 2,219 | ||
| Earnings Per Share | ||||||
| Basic EPS (in dollars per share) | $ 0.82 | $ 14.93 | $ 1.92 | $ 13.30 | ||
| Diluted EPS (in dollars per share) | $ 0.81 | $ 14.81 | $ 1.89 | $ 13.19 | ||
| ||||||
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($) $ in Millions |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Current assets | ||
| Cash and cash equivalents ($320 and $328 related to VIEs) | $ 2,923 | $ 2,135 |
| Marketable securities ($26 and $39 related to VIEs) | 120 | 59 |
| Accounts receivable, net ($134 and $142 related to VIEs) | 1,027 | 1,073 |
| Contract assets ($55 and $17 related to VIEs) | 1,440 | 1,146 |
| Investment in NuScale | 0 | 1,579 |
| Other current assets ($17 and $26 related to VIEs) | 184 | 450 |
| Total current assets | 5,694 | 6,442 |
| Noncurrent assets | ||
| PP&E, net ($40 and $41 related to VIEs) | 446 | 464 |
| Investments | 548 | 543 |
| Other assets ($7 and $17 related to VIEs) | 848 | 787 |
| Total noncurrent assets | 1,842 | 1,794 |
| Total assets | 7,536 | 8,236 |
| Current liabilities | ||
| Accounts payable ($142 and $205 related to VIEs) | 1,762 | 1,482 |
| Contract liabilities ($163 and $254 related to VIEs) | 541 | 633 |
| Accrued salaries, wages and benefits ($11 and $9 related to VIEs in both periods) | 571 | 621 |
| Other accrued liabilities ($24 and $31 related to VIEs) | 296 | 642 |
| Total current liabilities | 3,170 | 3,378 |
| Long-term debt | 1,072 | 1,070 |
| Deferred taxes | 5 | 6 |
| Other noncurrent liabilities ($4 and $3 related to VIEs) | 504 | 505 |
| Commitments and contingencies | ||
| Shareholders’ equity | ||
| Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 135,564,463 and 152,047,739 shares in 2026 and 2025, respectively | 1 | 2 |
| APIC | 0 | 443 |
| AOCI | (293) | (265) |
| Retained earnings | 2,978 | 3,064 |
| Total shareholders’ equity | 2,686 | 3,244 |
| NCI | 99 | 33 |
| Total equity | 2,785 | 3,277 |
| Total liabilities and equity | $ 7,536 | $ 8,236 |